Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Botulinum Toxin Type A (BoNT-A) Use for Post-Stroke Spasticity: A Multicenter Study Using Natural Language Processing and Machine Learning.
Antón MJ, Molina M, Pérez JG, Pina S, Tapiador N, De La Calle B, Martínez M, Ortega P, Ruspaggiari MB, Tudela C, Conejo M, Leno P, López M, Marhuenda C, Arias-Cabrales C, Maisonobe P, Herrera A, Candau E. Antón MJ, et al. Among authors: maisonobe p. Toxins (Basel). 2024 Aug 2;16(8):340. doi: 10.3390/toxins16080340. Toxins (Basel). 2024. PMID: 39195750 Free PMC article.
The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
Khan P, Riberto M, Frances JA, Chueire R, Amorim ACFG, Xerez D, Chung TM, Mercuri LHC, Longo AL, Lianza S, Maisonobe P, Ruiz-Schutz VC. Khan P, et al. Among authors: maisonobe p. Toxins (Basel). 2020 Dec 4;12(12):770. doi: 10.3390/toxins12120770. Toxins (Basel). 2020. PMID: 33291807 Free PMC article.
Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study.
Fheodoroff K, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Turner-Stokes L. Fheodoroff K, et al. Among authors: maisonobe p. Toxins (Basel). 2015 Apr 8;7(4):1192-205. doi: 10.3390/toxins7041192. Toxins (Basel). 2015. PMID: 25856546 Free PMC article.
Assessment of pain relief after four botulinum toxin A injection cycles in patients with post-stroke lower limb spasticity: A prospective, observational study.
Vázquez Doce A, De León García FJ, Mena A, Ortiz-Fernández L, Spottorno MP, Medina F, Maisonobe P, Herrera A, García I, Juan-García FJ; RELIEF investigators group. Vázquez Doce A, et al. Among authors: maisonobe p. Rehabilitacion (Madr). 2024 Jul-Sep;58(3):100856. doi: 10.1016/j.rh.2024.100856. Epub 2024 May 24. Rehabilitacion (Madr). 2024. PMID: 38795502
[Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR. Khat'kova SE, et al. Among authors: maisonobe p. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):39-48. doi: 10.17116/jnevro202112111139. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34932284 Russian.
Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
Turner-Stokes L, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Fheodoroff K. Turner-Stokes L, et al. Among authors: maisonobe p. BMJ Open. 2016 Jun 17;6(6):e011157. doi: 10.1136/bmjopen-2016-011157. BMJ Open. 2016. PMID: 27315835 Free PMC article.
73 results